|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Donald J. TindallPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: 2013 ed. Volume: 16 Dimensions: Width: 15.50cm , Height: 2.70cm , Length: 23.50cm Weight: 8.015kg ISBN: 9781489986627ISBN 10: 1489986626 Pages: 522 Publication Date: 23 June 2015 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsPreface.- Section 1: Cell Biology.- Stem Cells in the Normal and Malignant Prostate.- Role of Reactive Stroma in Prostate Cancer.- The Role of Cholesterol in Prostate Cancer.- Section 2: Genetics: PTEN in Prostate Cancer.- ETS fusion genes in prostate cancer.- Section 3: Cell Signaling.- Signaling Mechanisms of Vav3, a Guanine Nucleotide Exchange Factor and Androgen Receptor Coactivator, in Physiology and Prostate Cancer Progression.- Transforming Growth Factor-beta (TGF-b) in Prostate Cancer.- The p38 MAPK Pathway in Prostate Cancer.- NF-kappaB2/p52 in Prostate Cancer.- The functional role of DAB2IP, a homeostatic factor, in prostate cancer.- Tyrosine Kinases in Prostate Cancer.- Human prostatic acid phosphatase in prostate carcinogenesis.- Section 4: Hormonal.- Truncated Androgen Receptor Splice Variants in Prostate Cancer.- Biology and Clinical Relevance of Estrogen Receptors in Prostate Cancer.- Vitamin D and Prostate Cancer.- HDAC6 regulation of androgen signaling in prostate cancer.- Beyond the cell cycle: Implications of D-type cyclin deregulation in Pca.- Section 5: Cell Death.- Role of Par- in Prostate Cancer.- Autophagy and Prostate Cancer Therapeutics.- Index.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |